RecruitingNCT06680934
CABP2 Patient Registry and Natural History Study
Patient Registry for Individuals With CABP2-Associated Hearing Loss
Sponsor
University Medical Center Goettingen
Enrollment
100 participants
Start Date
Aug 16, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This registry is designed to collect comprehensive information about the molecular genetic diagnoses and clinical information of individuals with CABP2-associated hearing impairment to support a natural history study.
Eligibility
Inclusion Criteria1
- A molecular genetic diagnosis involving biallelic variants in CAPB2 and audiometry
Exclusion Criteria1
- Patients with evidence of non-CABP2 molecular genetic diagnoses
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTMolecular genetic testing and audiometry
Genetic testing and audiometry are the interventions of interest
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06680934
Related Trials
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
NCT073040241 location
Evaluating a Noise Reduction Algorithm With Cochlear Implant Users
NCT058053841 location
Clinical Evaluation of Frequency Allocation for Bimodal CI Users
NCT066639171 location
Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS)
NCT058474265 locations
Otoferlin Patient Registry and Natural History Study
NCT059460571 location